The benefits of medication in the long term treatment of schizophrenia - reduced risk of relapse, reduction of psychopathology - are well established. However, concern about the risk of tardive dyskinesia and the relative lack of improvement of social functioning have led to attempts to improve upon standard prophylactic treatment. The investigation's goal is to test the efficacy of three drug maintenance strategies and their relationship to psychosocial management strategies in patients with schizophrenia. Specifically, the effects of (1) continuous low dose, (2) discrete targeted early intervention, or (3) continuous standard dose antipsychotic drug treatment, each in combination with either (1) applied or (2) supportive family management, on schizophrenic patients in the community will be examined in terms of prevention of relapse, maintenance of remission, further reduction of psychopathology, improvement in social functioning, and reduction of side effects. Patients will be randomly assigned to these treatments resulting in a complete 3 x 2 factorial design. Combined treatment will continue for a one year period followed by an additional one year of treatment with the drug maintenance strategies alone. The investigation's design requires a multicenter collaborative study to permit generalization of findings to a range of treatment settings and to provide an adequate number of cases to test the hypothesis.

Project Start
1984-09-30
Project End
1992-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Smerud, Phyllis E; Rosenfarb, Irwin S (2008) The therapeutic alliance and family psychoeducation in the treatment of schizophrenia: an exploratory prospective change process study. J Consult Clin Psychol 76:505-10
Rosenfarb, Irwin S; Bellack, Alan S; Aziz, Nahid (2006) Family interactions and the course of schizophrenia in African American and White patients. J Abnorm Psychol 115:112-20
Blanchard, Jack J; Sayers, Steven L; Collins, Lindsay M et al. (2004) Affectivity in the problem-solving interactions of schizophrenia patients and their family members. Schizophr Res 69:105-17
Rosenfarb, Irwin S; Bellack, Alan S; Aziz, Nahid et al. (2004) Race, family interactions, and patient stabilization in schizophrenia. J Abnorm Psychol 113:109-15
Mueser, K T; Sengupta, A; Schooler, N R et al. (2001) Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden. J Consult Clin Psychol 69:3-12
Bellack, A S; Haas, G L; Schooler, N R et al. (2000) Effects of behavioural family management on family communication and patient outcomes in schizophrenia. Br J Psychiatry 177:434-9
Penn, D L; Mueser, K T; Doonan, R (1997) Physical attractiveness in schizophrenia. The mediating role of social skill. Behav Modif 21:78-85
Mueser, K T; Penn, D L; Blanchard, J J et al. (1997) Affect recognition in schizophrenia: a synthesis of findings across three studies. Psychiatry 60:301-8
Bellack, A S; Blanchard, J J; Mueser, K T (1996) Cue availability and affect perception in schizophrenia. Schizophr Bull 22:535-44
Mueser, K T; Doonan, R; Penn, D L et al. (1996) Emotion recognition and social competence in chronic schizophrenia. J Abnorm Psychol 105:271-5

Showing the most recent 10 out of 38 publications